Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.
about
KASL clinical practice guidelines: management of chronic hepatitis BEfficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-AnalysisCurrent and future directions for treating hepatitis B virus infectionNucleoside/nucleotide analogues in the treatment of chronic hepatitis BEfficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsHepatitis B Therapy in PregnancyClinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B.Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysisTenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patientsCurrent Antiviral Therapy of Chronic Hepatitis B: Efficacy and SafetySimilar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.Management of hepatitis B in developing countries.Reassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysis.Management of hepatitis B during pregnancy.Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B.Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.Advances in Nucleotide Antiviral Development from Scientific Discovery to Clinical Applications: Tenofovir Disoproxil Fumarate for Hepatitis B.Prolonged entecavir therapy is not effective for HBeAg seroconversion in treatment-naive chronic hepatitis B patients with a partial virological response.Impact of partial reimbursement on hepatitis B antiviral utilization and adherenceOptimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is PregnantRandomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovirComparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a systematic review and meta-analysisEfficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis BOptions for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FranceEfficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study.Then and now: the progress in hepatitis B treatment over the past 20 years.Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?SASLT practice guidelines for the management of hepatitis B virus.Management of Antiviral Resistance in Chronic Hepatitis B.Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?Antiviral drugs for HBV liver disease.Hepatitis B therapy.The management of chronic hepatitis B in Asian Americans.Review article: current antiviral therapy of chronic hepatitis B.Adefovir dipivoxil in chronic hepatitis B: history and current uses.Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.
P2860
Q26752475-B8D46410-7A71-45C8-BF82-87C1B0353E07Q26765932-97F52928-BD4F-4D5C-BEFE-D40B6B25890FQ26851240-1B0DF082-50FE-45E9-8CB9-12472050F710Q27030828-680B8B51-EBD4-401F-A68D-5800D98118E0Q28540372-AB721ABC-B50D-45D5-8535-57D2046B647DQ34154952-F6F315C2-2E06-4BC7-97F9-37D2CF3AD0F0Q34797281-80045ADE-57E6-427E-A802-E816D3A61389Q34847029-5EED0369-FD6D-4C9C-8754-4560F2745C91Q35231822-8DC750FE-6A11-4DD1-9895-9B15E77E0142Q35535861-DCDF594C-EED8-494C-AF98-EA481C0C17C8Q35594210-92FFCF49-24F4-475C-8380-E9ACB5BB098CQ35635637-8597CE24-D2A3-4548-8F25-A4FB1835E24EQ35821198-DE72C65D-21FC-4985-82B2-3DA72D69A0E3Q35838778-9CC0DD6E-B579-4F91-A808-8549A3F14ECCQ35844432-B0877711-C51F-49C2-A176-3C4AA415A182Q35846564-63CC6049-4509-4908-9760-4645A9B986FDQ35906015-EBE35AA2-1249-4DB0-8900-225978D7F99DQ35960972-A78F3AD1-1264-45FA-9651-3450CC799BA2Q35992395-D0710CAF-6B47-415A-8948-7D48E0A203C2Q35999165-323C059D-12F4-4883-BDA2-89FF3ECAF154Q36018658-174143D1-7F78-4B9C-841A-EDA00944A716Q36492635-A95A8E1E-8F49-49F0-8480-80D2AEC40A04Q36757579-2C732B36-ED4F-47B5-A87C-5280527EE761Q36779207-A974A483-BFA1-4671-903C-6A766771557FQ37229851-F4910850-A78E-4B7E-B414-60B488149535Q37250436-70FCA8F7-D18E-46A8-96ED-ECBDAFCBBDB3Q37564039-86E324AE-218F-448D-BA13-E9DB6515A286Q37573939-A10CAF1D-1ED2-4EF4-A453-3BF1129A8A2CQ37581346-12D0984F-6AF7-4DB6-A666-DF9B73861C68Q37606550-0580F864-D619-4831-AAAB-D3C7E2A92331Q37634822-350D50E2-B6CE-410B-B2AA-381319A51ACAQ37696029-BCB6F967-FE06-4799-9CA3-93FF2EF4AC10Q37825532-B2B3BDA7-0B2D-4141-8C93-F475D12371F2Q37825909-91F417DE-C203-4C0B-A638-D99F99F0EFF6Q37855531-E58D476F-5580-4347-9643-C7236F51D669Q37936321-CC354B51-54B8-4F2B-8003-9D629441B842Q37943006-49C350C7-B118-4B51-9989-C4F5191C6CBFQ37975548-6E7A6EAD-2214-42FA-B904-2C0C1D64F2A9Q38038690-245F54E1-0260-49D8-AA52-E1AA47DD0C38Q38071396-87598F62-A9DA-4E16-8073-408F974C691B
P2860
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@en
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@nl
type
label
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@en
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@nl
prefLabel
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@en
Tenofovir is effective alone o ...... c-hepatitis B virus infection.
@nl
P2093
P50
P1433
P1476
Tenofovir is effective alone o ...... ic-hepatitis B virus infection
@en
P2093
Andrea Snow-Lampart
Bernd Moller
David Frederick
Emilio Suarez
Fabien Lavocat
Franck Rousseau
Jeff Sorbel
Katyna Borroto-Esoda
Patrick Marcellin
P304
P356
10.1053/J.GASTRO.2010.06.053
P407
P577
2010-06-20T00:00:00Z